Avista Healthcare Public Acquisition Corp.

Status: Deal Closed
U=S+W W=S/2@11.5
IPO Proceeds, $M $310.00M
IPO Date Oct 11, 2016
CEO David Burgstahler
Left Lead Credit Suisse
IPO Cash in Trust 100.0%
SPAC Tenor 24+[4]
IPO Sector Healthcare

Healthcare (North America or Europe)

IPO Geography Global
Target Company Organogenesis
Deal Announced Aug 17, 2018
Deal Size, $M $673.00M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Dec 10, 2018
Amendment Vote TBD
Closing Date Dec 11, 2018
Formerly AHPA ORGO ORGOW

Sign up for Free Trial

No credit card required

Sign in for more on Avista Healthcare Public Acquisition Corp.:

  • Structure and cap table
  • 8 directors & officers
  • 47 filings and events
  • 2 underwriters
  • 1 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Thompson Dean 58 Executive Chairman
David Burgstahler 48 President, CEO & Director
John Cafasso 44 CFO
Benjamin Silbert 46 General Counsel & Secretary
Håkan Björklund 60 Director
Charles Harwood 63 Director
Brian Markison 57 Director
Robert O'Neil 66 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Credit Suisse BR 29,250,000 units
I-Bankers Securities 750,000
30,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 47 filings.

Shareholders

Sign in to view shareholders 13F filing data.